PharVision Advisers’s Vertical Aerospace EVTL Stock Holding History

PharVision Advisers’s Portfolio EVTL Stock Details EVTL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-56,565	Closed	-$294K	–	782
2025 Q3	$294K	Buy	+56,565	New	+$314K	0.17%	235

Other funds holding EVTL

MCM

Mudrick Capital Management New York $174M AUM 32.43% 1-Year Est. Return

SCM

Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

MCM

Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

IMC

Inherent Management Corp New York $197M AUM 23.09% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Kotler Kevin $427M AUM

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

PharVision Advisers's EVTL Position: Q4 2025 in Review

PharVision Advisers sold out of Vertical Aerospace (EVTL) in Q4 2025, closing a stake of 56,565 shares — an estimated $294K sold.

PharVision Advisers first reported a position in EVTL in Q3 2025 and held it in 1 quarter. The position peaked at $294K in Q3 2025. 74 funds tracked by Wall St. Rank hold EVTL as of Q4 2025.

PharVision Advisers reported no remaining Vertical Aerospace position as of Q4 2025 after selling out during the quarter.
PharVision Advisers sold 56,565 Vertical Aerospace shares in Q4 2025, an estimated $294K.
PharVision Advisers first reported a position in Vertical Aerospace in Q3 2025 and held it in 1 quarter.
PharVision Advisers's Vertical Aerospace position peaked at $294K in Q3 2025.
74 funds tracked by Wall St. Rank held Vertical Aerospace as of Q4 2025.

Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.